Press Release: Kwambio : ADAM: Innovative Project for 3D Bioprinting of Organic Bones' Structures

GROTON, Conn.--(BUSINESS WIRE)--ADAM sets new milestone in medical technology by launching the 3D bioprinting of organic bone structures. ADAM has started passing the regulatory requirements to begin preclinical trials this month. ADAM is a biotechnical initiative, cofounded by Kwambio (the 3D printing experts) and WeFund Ventures (an early stage venture fund). It is based in BioCT Innovation Commons (Groton, CT), and has already gained support from Applied Medical and Techstars. The core of AD